Sandu Pharmaceuticals Ltd vs Venmax Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Sandu Pharmaceuticals Ltd is ₹ 37.75 as of 18 May 15:30 . The P/E Ratio of Sandu Pharmaceuticals Ltd is 33.3 as of March 2023 .The P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd is 0 as of March 2023 . The Market Cap of Sandu Pharmaceuticals Ltd is ₹ 50.43 crore as of March 2023 .The Market Cap of Venmax Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2023 . The revenue of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 14.14 crore as compare to the Dec '24 revenue of ₹ 18.4 crore. This represent the decline of -23.15% The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 0.52 crore as compare to the Dec '24 ebitda of ₹ 1.02 crore. This represent the decline of -49.02% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0.33 crore over 4 quarters. This represents a CAGR of 94.12% The net profit of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of 0.0% The Dividend Payout of Sandu Pharmaceuticals Ltd changed from 36.33 % on March 2021 to 49.86 % on March 2025 . This represents a CAGR of 6.54% over 5 yearsThe Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Limited (SPL) was established in 1987.
The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name 'SANDU' and is having a plant unit in Goa. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.

FAQs for the comparison of Sandu Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Sandu Pharmaceuticals Ltd or Venmax Drugs & Pharmaceuticals Ltd?

Market cap of Sandu Pharmaceuticals Ltd is 36 Cr while Market cap of Venmax Drugs & Pharmaceuticals Ltd is 26 Cr

What are the key factors driving the stock performance of Sandu Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd?

The stock performance of Sandu Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sandu Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd?

As of May 18, 2026, the Sandu Pharmaceuticals Ltd stock price is INR ₹37.75. On the other hand, Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹23.07.

How do dividend payouts of Sandu Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Sandu Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.